Exploring the role of prolactin in psoriasis

Archives of Dermatological Research

Volumn 304, Issue 2, 2012, Pages 115-118

  Langan, Ewan A ^a,b   Griffiths, Christopher E M ^a   Paus, Ralf ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Prolactin; Psoriasis; Skin

Indexed keywords

CYTOKINE; PROLACTIN; PROLACTIN RECEPTOR; PROPYLTHIOURACIL; TACALCITOL;

B LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE SEVERITY; EMOTIONAL STRESS; HORMONE SYNTHESIS; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; MENTAL STRESS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN EXPRESSION; PSORIASIS; SHORT SURVEY; SMOKING; T LYMPHOCYTE;

ANIMALS; CELL GROWTH PROCESSES; GENE EXPRESSION REGULATION; HAIR; HUMANS; IMMUNOMODULATION; KERATINS; PROLACTIN; PSORIASIS; SKIN; STRESS, PSYCHOLOGICAL;

EID: 84857898219     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-012-1208-6     Document Type: Short Survey

References (47)

1. Al'Abadie MS, Kent GG, Gawkrodger DJ (1994) The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 130(2):199-203 (Pubitemid 24204615)
2. Angioni AR, Lania A, Cattaneo A, Beck-Peccoz P, Spada A (2005) Effects of chronic retinoid administration on pituitary function. J Endocrinol Invest 28(11):961-964 (Pubitemid 43265759)
3. Arnetz BB, Fjellner B, Eneroth P, Kallner A (1985) Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 47(6):528-541 (Pubitemid 16200081)
4. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW (1996) Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17(6):639-669 (Pubitemid 26425260)
5. Bernton E, Bryant H, Holaday J, Dave J (1992) Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A. Brain Behav Immun 6(4):394-408 (Pubitemid 23054161)
6. Biswas R, Roy T, Chattopadhyay U (2006) Prolactin induced reversal of glucocorticoid mediated apoptosis of immature cortical thymocytes is abrogated by induction of tumor. J Neuroimmunol 171(1-2):120-134 (Pubitemid 41832283)
7. Chikanza IC (1999) Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann N Y Acad Sci 876:119-130
8. De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A (2005) Prolactin and autoimmunity. Pituitary 8(1):25-30 (Pubitemid 44680082)
9. Dilme-Carreras E, Martin-Ezquerra G, Sanchez-Regana M, Umbert-Millet P (2011) Serum prolactin levels in psoriasis and correlation with cutaneous disease activity. Clin Exp Dermatol 36(1):29-32
10. El-Khateeb EA, Zuel-Fakkar NM, Eid SM, Abdul-Wahab SE (2011) Prolactin level is significantly elevated in lesional skin of patients with psoriasis. Int J Dermatol 50(6):693-696
11. Evers AW, Verhoeven EW, Kraaimaat FW, De Jong EM, De Brouwer SJ, Schalkwijk J, Sweep FC, Van De Kerkhof PC (2010) How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol 163(5):986-991
12. Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9(6):461-467 (Pubitemid 350305203)
13. Foitzik K, Krause K, Conrad F, Nakamura M, Funk W, Paus R (2006) Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol 168(3):748-756 (Pubitemid 43327727)
14. Fomicheva EE, Nemirovich-Danchenko EA, Korneva EA (2004) Immunoprotective effects of prolactin during stress-induced immune dysfunction. Bull Exp Biol Med 137(6):544-547 (Pubitemid 39303147)
15. Fortune DG, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, Main CJ, Griffiths CE (2003) Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 139(6):752-756 (Pubitemid 36705942)
16. Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80(4):1523-1631
17. Giasuddin AS, El-Sherif AI, El-Ojali SI (1998) Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology 197(2):119-122 (Pubitemid 28395836)
18. Goffin V, Binart N, Touraine P, Kelly PA (2002) Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47-67 (Pubitemid 34259225)
19. Guilhou JJ, Guilhou E (1982) Bromocriptine treatment of psoriasis. Arch Dermatol Res 273(1-2):159-160
20. Holt RI (2008) Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists. J Psychopharmacol 22(2 Suppl):28-37
21. Kanda N, Shibata S, Tada Y, Nashiro K, Tamaki K, Watanabe S (2009) Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 39(4):996-1006
22. Kanda N, Watanabe S (2007) Prolactin enhances interferon-gamma- induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 148(5):2317-2325 (Pubitemid 46997044)
23. Kimball AB, Szapary P, Mrowietz U, Reich K, Langley RG, You Y, Hsu MC, Yeilding N, Rader DJ, Mehta NN (2011) Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol. doi:10.1016/j.jaad.2011.06.035
24. Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S (2010) Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (3):CD006654. doi:10.1002/14651858
25. Kotrulja L, Tadinac M, Joki-Begi NA, Gregurek R (2010) A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients. Acta Derm Venereol 90(3):251-256
26. Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, Paus R (2010) Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab 21(9):569-577
27. Langan EA, Ramot Y, Goffin V, Griffiths CE, Foitzik K, Paus R (2010) Mind the (gender) gap: does prolactin exert gender and/or site-specific effects on the human hair follicle? J Invest Dermatol 130(3):886-891
28. Langan EA, Ramot Y, Hanning A, Poeggeler B, Biro T, Gaspar E, Funk W, Griffiths CE, Paus R (2010) Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br J Dermatol 162(5):1127-1131
29. Lennartsson AK, Jonsdottir IH (2011) Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology 36(10):1530-1539
30. Lu Z, Hasse S, Bodo E, Rose C, Funk W, Paus R (2007) Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 16(1):37-44 (Pubitemid 44890349)
31. Mackin P, Waton A, Nulkar A, Watkinson HM (2011) Prolactin and smoking status in antipsychotic-treated patients. J Psychopharmacol 25 (5):698-703
32. Malligarjunan H, Gnanaraj P, Subramanian S, Elango T, Dayalan H (2011) Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients. Clin Biochem 44(14-15):1209-1213
33. Mukherjee A, Helbert M, Ryder WD, Borrow R, Davis JR, Shalet SM (2009) Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults. Clin Exp Immunol 156(2):271-277
34. Nagy E, Berczi I (1991) Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 128(6):2776-2784
35. Paus R (1991) Does prolactin play a role in skin biology and pathology? Med Hypotheses 36(1):33-42
36. Pellegrini I, Lebrun JJ, Ali S, Kelly PA (1992) Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 6(7):1023-1031
37. Ramot Y, Biro T, Tiede S, Toth BI, Langan EA, Sugawara K, Foitzik K, Ingber A, Goffin V, Langbein L, Paus R (2010) Prolactin - a novel neuroendocrine regulator of human keratin expression in situ. Faseb J 24(6):1768-1779
38. Richards HL, Ray DW, Kirby B, Mason D, Plant D, Main CJ, Fortune DG, Griffiths CE (2005) Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol 153(6):1114-1120 (Pubitemid 41779564)
39. Slominski A, Malarkey WB, Wortsman J, Asa SL, Carlson A (2000) Human skin expresses growth hormone but not the prolactin gene. J Lab Clin Med 136(6):476-481
40. Sobrinho LG (2003) Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary 6(1):35-39
41. Stevens A, Ray DW, Worthington J, Davis JR (2001) Polymorphisms of the human prolactin gene - implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus 10(10):676-683 (Pubitemid 33041659)
42. Tomei F, Ciarrocca M, Cherubini E, Rosati MV, Monti C, Capozzella A, Tomei G (2006) Prolactin levels in workers exposed to chemical, physical and psycho-social urban stressors. J Occup Health 48(4):253-260 (Pubitemid 44664516)
43. Walker AM, Robertson MT, Jones CJ (1989) Distribution of a prolactin-like material in human eccrine sweat glands. J Invest Dermatol 93(1):50-53 (Pubitemid 19183311)
44. Weber G, Frey H (1986) Treatment of psoriasis arthropathica with bromocriptine. Z Hautkr 61(20):1456-1466
45. Weber G, Neidhardt M, Frey H, Galle K, Geiger A (1981) Treatment of psoriasis with bromocriptin. Arch Dermatol Res 271(4):437-439 (Pubitemid 12253899)
46. Webster Marketon JI, Glaser R (2008) Stress hormones and immune function. Cell Immunol 252(1-2):16-26
47. Zouboulis CC (2004) The human skin as a hormone target and an endocrine gland. Hormones (Athens) 3(1):9-26